FDA Inspection
Medix Biochemica USA, Inc.Medix Biochemica USA, Inc. – FDA Inspection, Sep 5, 2012
Record Details
This FDA Inspection record concerns Medix Biochemica USA, Inc., with an inspection on September 5, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Medix Biochemica USA, Inc.
- Inspection Date
- September 5, 2012
- Product Type
- Biologics
View Company Profile
ID · d81b914f-7e3b-484d-bc8d-6e19c361a713
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 797510
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Medix Biochemica USA, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Medix Biochemica USA, Inc.
- FDA Inspection 1341124 - 2026-09-29
- FDA Inspection 1205335 - 2023-05-03
- FDA Inspection 1040189 - 2017-12-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.